Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Cash flows from operating activities:
Net (loss) earnings	$ (1,269.1)	$ (669.9)	$ 16.8
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	4,506.5	2,216.1	2,019.3
Deferred income tax expense (benefit)	675.7	(213.2)	(192.6)
Litigation settlements and other contingencies, net	323.7	101.1	(11.5)
Loss from equity method investments	61.9	48.4	62.1
Share-based compensation expense	111.2	79.2	56.8
Other non-cash items	411.8	366.4	360.6
Changes in operating assets and liabilities:
Accounts receivable	59.3	78.7	(20.0)
Inventories	(427.6)	(741.9)	(512.9)
Trade accounts payable	(70.4)	(82.7)	(96.3)
Income taxes	(699.6)	3.6	57.9
Other operating assets and liabilities, net	(666.5)	46.0	63.5
Net cash provided by operating activities	3,016.9	1,231.8	1,803.7
Cash flows from investing activities:
Cash received (paid) for acquisitions, net of cash acquired	277.0	415.8	(148.7)
Capital expenditures	(457.2)	(243.0)	(213.2)
Payments for product rights and other, net	(52.2)	(438.2)	(192.8)
Proceeds from sale of property, plant and equipment	18.3	2.1	0.0
Proceeds from sale of assets and subsidiaries	96.7	20.0	28.0
Purchase of marketable securities	(30.2)	(104.8)	(25.8)
Proceeds from the sale of marketable securities	29.8	47.0	27.1
Net cash used in investing activities	(117.8)	(301.1)	(525.4)
Cash flows from financing activities:
Proceeds from issuance of long-term debt	1,710.1	983.3	7.4
Payments of long-term debt	(4,201.3)	(2,484.2)	(1,108.5)
Payments of financing fees	(7.0)	(2.0)	(3.0)
Change in short-term borrowings, net	392.1	1,099.6	(1.8)
Proceeds from exercise of stock options	0.0	0.6	8.1
Taxes paid related to net share settlement of equity awards	(17.4)	(7.9)	(8.4)
Contingent consideration payments	(28.6)	(48.5)	(60.3)
Cash dividends paid	(399.0)	0.0	0.0
Non-contingent payments for product rights	(456.0)	(143.3)	0.0
Other items, net	(4.9)	(3.3)	(2.5)
Net cash used in financing activities	(3,012.0)	(605.7)	(1,169.0)
Effect on cash of changes in exchange rates	(30.9)	33.8	(7.5)
Net (decrease) increase in cash, cash equivalents and restricted cash	(143.8)	358.8	101.8
Cash, cash equivalents and restricted cash — beginning of period	850.0	491.1	389.3
Cash, cash equivalents and restricted cash — end of period	706.2	850.0	491.1
Non-cash transactions:
Common stock issued for the Combination	0.0	10,727.5	0.0
Cash paid during the period for:
Income taxes	641.7	324.4	278.6
Interest	$ 684.8	$ 555.4	$ 470.6